1. Home
  2. AEHR vs PHAT Comparison

AEHR vs PHAT Comparison

Compare AEHR & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aehr Test Systems

AEHR

Aehr Test Systems

HOLD

Current Price

$89.83

Market Cap

858.8M

Sector

Industrials

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$11.32

Market Cap

894.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEHR
PHAT
Founded
1977
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
858.8M
894.0M
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
AEHR
PHAT
Price
$89.83
$11.32
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$29.50
$19.83
AVG Volume (30 Days)
4.3M
1.1M
Earning Date
04-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.72
EPS
N/A
N/A
Revenue
$58,968,000.00
$175,110,000.00
Revenue This Year
N/A
$93.04
Revenue Next Year
$71.04
$58.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
216.93
52 Week Low
$8.02
$2.21
52 Week High
$102.48
$18.31

Technical Indicators

Market Signals
Indicator
AEHR
PHAT
Relative Strength Index (RSI) 68.14 44.33
Support Level $21.95 $10.47
Resistance Level N/A $11.54
Average True Range (ATR) 8.35 0.90
MACD -0.70 -0.13
Stochastic Oscillator 63.80 37.02

Price Performance

Historical Comparison
AEHR
PHAT

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: